Savara (SVRA) Other Non Operating Income (2010 - 2026)

Savara's (SVRA) quarterly Other Non Operating Income came in at -$216000.0 in Q1 2026, down 460.0% year-on-year from $60000.0 in Q1 2025, and down 118.26% on a QoQ basis from $1.2 million in Q4 2025.

Savara (SVRA) Other Non Operating Income (2010 - 2026) Analysis & Trends

Savara (SVRA) has 17 years of Other Non Operating Income data on file, last reported at -$216000.0 in Q1 2026.

  • On a quarterly basis, Other Non Operating Income fell 460.0% year-over-year to -$216000.0 in Q1 2026; TTM through Mar 2026 was $2.2 million, a 79.69% decrease from a year earlier, with the FY2025 full-year figure at $4.7 million, down 35.61% from the prior year.
  • Other Non Operating Income for Q1 2026 stood at -$216000.0, down from $1.2 million in the prior quarter.
  • Over the last five years, Other Non Operating Income for SVRA reached as high as $7.5 million in Q4 2024 and fell as low as -$254000.0 in Q1 2022.
  • Historically, Other Non Operating Income has averaged $916941.2 across 5 years, with a median of $60000.0 in 2025.
  • Across the five-year window, Other Non Operating Income jumped 210800.0% in 2024 and slumped 460.0% in 2026, its largest moves.
  • Year by year, Other Non Operating Income stood at -$40000.0 in 2022, then soared by 3927.5% to $1.5 million in 2023, then jumped by 388.63% to $7.5 million in 2024, then slumped by 84.19% to $1.2 million in 2025, then slumped by 118.26% to -$216000.0 in 2026.
  • Per Business Quant data, the three most recent Other Non Operating Income figures were -$216000.0 in Q1 2026, $1.2 million in Q4 2025, and $146000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Savara 1.24 Bn 1.24 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -216,000.00
Dec 31, 2025 1.18 Mn
Sep 30, 2025 146,000.00
Jun 30, 2025 1.04 Mn
Mar 31, 2025 60,000.00
Dec 31, 2024 7.48 Mn
Sep 30, 2024 2.11 Mn
Jun 30, 2024 947,000.00
Mar 31, 2024 -21,000.00
Dec 31, 2023 1.53 Mn
Sep 30, 2023 1,000.00
Jun 30, 2023 33,000.00
Mar 31, 2023 1.56 Mn
Dec 31, 2022 -40,000.00
Sep 30, 2022 -8,000.00
Jun 30, 2022 42,000.00
Mar 31, 2022 -254,000.00
Dec 31, 2021 767,000.00
Sep 30, 2021 -574,000.00
Jun 30, 2021 43,000.00